Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.
about
Association of the gene polymorphisms IFN-gamma +874, IL-13 -1055 and IL-4 -590 with patterns of reinfection with Schistosoma mansoniNovel therapeutic and prevention approaches for schistosomiasis: reviewInterleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasisIL-10 blocks the development of resistance to re-infection with Schistosoma mansoniTrick or treat: the role of vaccines in integrated schistosomiasis control.A Schistosoma mansoni epitope recognized by a protective monoclonal antibody is identical to the stage-specific embryonic antigen 1Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection.Community-wide treatment of schistosomiasis with praziquantel.Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities.Detection of Schistosoma mansoni membrane antigens by immunoblot analysis of sera of patients from low-transmission areas.Human immune responses to Schistosoma mansoni vaccine candidate antigens.Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapyCorrelation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans.Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin ESchistosomiasis--a rich vein of research.A Meta-Analysis of Experimental Studies of Attenuated Schistosoma mansoni Vaccines in the Mouse Model.Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni.Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni.Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.Human schistosome infection and allergic sensitisation.Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies.Molecular characterization of two Schistosoma mansoni proteins sharing common motifs with the vif protein of HIV-1.Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.Schistosoma mansoni antigens differentially recognized by resistant WEHI 129/J mice.Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments.Epidemiology of schistosomiasis in two high-risk communities of south Cote d'Ivoire with particular emphasis on pre-school-aged childrenHuman eosinophils modulate peripheral blood mononuclear cell response to Schistosoma mansoni adult worm antigen in vitroImmunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4.Prevalence of Schistosoma mansoni Infection in Four Health Areas of Kisantu Health Zone, Democratic Republic of the Congo.Recent advances in the characterization of genetic factors involved in human susceptibility to infection by schistosomiasis.Biophysical studies of the schistosome surface and their relevance to its properties under immune and drug attack.Human IgE responses to rSm22.6 are associated with infection intensity rather than age per se, in a recently established focus of Schistomiasis mansoni.Effect of chemotherapy on immune response to egg antigens of Schistosoma mansoni in chronically infected children from areas of low transmission.Humoral immune response of children with chronic schistosomiasis. Isotype recognition of adult worm antigens.Observations on the effects of different chemotherapy strategies on the transmission of Schistosoma mansoni in Machakos District, Kenya, measured by long-term snail sampling and cercariometry.Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytesRelative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel.A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.The antibody recognition profiles of humans naturally infected with Ascaris lumbricoides.Possible protective immunity in human opisthorchiasis.
P2860
Q21092301-788A19BA-8717-4062-B197-11D36858BEE8Q27008897-DEF792A4-62F5-4BFA-9AB4-A597EE1AD870Q28281586-E65F447D-1E9C-4633-8A01-09884F4F75C2Q28476429-035E33DF-852C-4097-84D0-1573C3A18147Q33346303-21F7A448-13E4-4233-9304-E05BEF1719EAQ33607940-2664CD97-3463-489A-80E1-533578864E3DQ33615961-DC804605-B964-4A11-BED6-2C79F3109576Q33711583-1566ADE1-20EF-4839-826D-15A0DDCE6EA5Q33808603-152CC19F-94B3-4D1A-8D9A-19C2B6FE7875Q33858931-E29504BB-FDD7-4B20-910B-C59C0A45D306Q34004360-6D6CC238-ABC1-41AD-AD84-779E21F5834EQ34005571-ED74CFC1-7288-46BA-A70C-A080A91EAAADQ34492595-BCE4510B-59F5-49A6-B66B-4FF1F11ABAE4Q34760480-9287DAFF-F3B3-4E26-81C1-D59D12E0174AQ34998245-1434EF4B-9455-4945-81CA-BB640DC95FEDQ35128551-7384E7BC-014C-4D97-B03A-56993EFCBF82Q35196613-ED238317-06A7-4EEA-BE37-9EE4B338DA18Q35500705-19B81543-A7D2-444F-9B5C-CB85417582E7Q35938440-2B1CBDC6-1341-4466-8E9C-DCB0F5A2D16EQ36210573-97193CED-9DD9-4F65-8D39-75AE3728099AQ36353120-58AF7AD2-B9C0-4A6F-82F7-C38D0A3D3986Q36736289-420EB3E9-E51F-4F65-9E0C-6D2B6B98A694Q36882459-2D9FFF24-CB09-4DF5-AA84-C9F216172BF3Q37000939-B026A659-3B2C-4201-A46B-0BA833D81FF4Q37085574-C60A7A07-42F5-4EBA-B654-0E0A5780894DQ37107975-08725BDD-FB3C-45F5-97F7-E84A5628481AQ37152231-AD512515-B81B-42B8-9AC3-41FB030DE4D4Q37191336-80665909-4D41-495E-86AE-550B2537831BQ37192449-9491D4AA-A906-446D-9B88-9EEDA39B6CD3Q37200815-CAFD8980-8CF2-43EC-BB7D-6F15CC76B802Q38726539-CB33BE21-80F3-4EE0-B788-EC452FFE1D67Q38887383-C299FF5B-53CD-46D8-AB8C-154877B2D672Q39311161-B8A62386-7DBB-4CB2-A9F1-D0E2CB138F9EQ39311168-E146A2AD-7327-491A-8D02-292297F4C624Q39495130-B47EFE81-1427-4A01-AFCF-500C1AAC3916Q39511879-BBFE9EE6-BAB4-4C65-9D2F-C6C44CF9EF4DQ39544940-96009EE1-ED62-46F6-A7D9-4AC7C9C50A1BQ40545484-5EC0153C-0B6C-47EA-9530-33CF1036EDCFQ41287180-F335786D-1DF7-4C85-A2D2-619925C0D458Q41663612-78E3FA3D-8034-4EBC-B122-FF159F0A477D
P2860
Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Immunity after treatment of hu ...... sis of their immune responses.
@en
Immunity after treatment of hu ...... sis of their immune responses.
@nl
type
label
Immunity after treatment of hu ...... sis of their immune responses.
@en
Immunity after treatment of hu ...... sis of their immune responses.
@nl
prefLabel
Immunity after treatment of hu ...... sis of their immune responses.
@en
Immunity after treatment of hu ...... sis of their immune responses.
@nl
P2093
P1476
Immunity after treatment of hu ...... sis of their immune responses.
@en
P2093
Butterworth AE
Cordingley JS
Kariuki HC
P304
P356
10.1016/0035-9203(85)90391-8
P577
1985-01-01T00:00:00Z